Cellectar Biosciences Inc
(CLRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Operating Expenses | 3,200 | 3,630 | 3,885 | 3,088 | 2,905 |
| Operating Income | -3,200 | -3,630 | -3,885 | -3,088 | -2,905 |
| Other Income | 13 | 8 | 57 | 73 | -16 |
| Pre-tax Income | -3,188 | -3,622 | -3,828 | -3,015 | -2,921 |
| Net Income Continuous | -3,188 | -3,622 | -3,828 | -3,015 | -2,921 |
| Net Income | $-3,188 | $-3,622 | $-3,828 | $-3,015 | $-2,921 |
| EPS Basic Total Ops | -138.14 | -228.23 | 54.05 | -495.50 | -507.51 |
| EPS Basic Continuous Ops | -137.47 | -227.84 | 69.55 | -284.27 | -506.53 |
| EPS Diluted Total Ops | -138.14 | -228.23 | 54.05 | -495.50 | -507.51 |
| EPS Diluted Continuous Ops | -137.47 | -227.84 | 69.55 | -284.27 | -506.53 |
| EBITDA(a) | $-3,167 | $-3,597 | $-2,177 | $-3,072 | $-2,888 |